Aplidin (plitidepsin)
Published: Oct 15, 2008 8:00 am
| Brand Name: | Aplidin |
| Generic Name: | plitidepsin |
| Code Name: | |
| Company: | PharmaMar, SA |
| FDA Clinical Phase: | 3 |
Description:
Aplidin is derived from a compound found in tunicates which shows promise in shrinking tumors. The specific marine organism is Aplidium albicans.
Clinical Trials:
For a list of clinical trials studying Aplidin for the treatment of multiple myeloma, see ClinicalTrials.gov.
Official website for Aplidin: http://www.pharmamar.com/en/pipeline/aplidin.cfm
Source: Wikipedia, Aplidine, http://en.wikipedia.org/wiki/Aplidine (as of November 14, 2009)
Related Articles:
- Beacon NewsFlashes – June 11, 2010
- New Myeloma Drugs Target Different Mechanisms: Misfolded Proteins
- Plitidepsin Is Not Very Effective For Multiple Myeloma But Merits Further Study In Combination With Other Treatments
- Beacon NewsFlashes – November 10, 2010
- Antibody Treatment In Mice Shows Antitumor Activity
Leave a comment